AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Effect of Dairy Intake on Body Weight and Composition and Metabolic Health in Adolescents and Seniors

RecruitingNAAges 14 Years - 80 YearsAllUniversity of Toronto
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this study is to examine how regular dairy intake affects body weight, body composition, and metabolic health in overweight and obese adolescents (ages 15-18) and older adults (ages 60-80) over six months. We are inviting eligible individuals to participate in this study at the Nutrition Intervention Center, Department of Nutritional Sciences, University of Toronto. Participants will be randomly divided into two groups. The intervention (dairy) group will consume three servings of dairy per day (milk, yogurt, and cheese) before breakfast, lunch, and dinner. The control (low-dairy) group will continue their usual diet, keeping dairy intake to less than one serving per day. Participants will have biweekly sessions with a registered dietitian to be guided to follow Canada's Food Guide, monitor their dietary intake and ensure compliance with their assigned group. In addition, th

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria (long-term Study): * Age 15-18 years old (adolescents) or 60-80 years old (seniors) * BMI z-score \>+1SD, \<+2SD (adolescents) or BMI 25-34.9 kg/m2 (seniors) * Waist circumference \> 80 cm for women and \> 94 cm for men (seniors) * FBG 5.6-6.9 mmol/L (prediabetes) * Willing to follow Canada's Food Guide * Willing to maintain current dietary supplement use throughout the study. * Willing to abstain from alcohol consumption for 24 hours before all test visits. * Willing to avoid vigorous physical activity for 24 hours before all test visits. * Understands the study procedures and is willing to provide informed consent by the parent/guardian and assent by participant to participate in the study and authorization to release relevant protected health information to the study investigator. Exclusion Criteria: * Fasting BG โ‰ฅ 7 mmol/L * Blood pressure systolic โ‰ฅ 130mmHg or diastolic โ‰ฅ 80mmHg (adolescents) or systolic โ‰ฅ 140 mmHg or diastolic pressure โ‰ฅ 90 mmHg * Smoking (tobacco and/or cannabis product use in the last 6 months) * Thyroid problems * History of CVDs, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, any malabsorption syndrome, pancreatitis, gallbladder, or biliary disease. * Presence of gastrointestinal disorder or surgeries within the past year. * Use of the prescription or non-prescription drugs, herbal or nutritional supplements known to affect the outcome of the study as per the investigator's judgment (including prebiotics and probiotics). * Known to be pregnant, lactating, or not postmenopausal for at least a year and/or is taking hormonal treatments * Unwillingness or inability to comply with the experimental procedures * Known intolerance, sensitivity, or allergy to dairy, gluten, or any other study treatments. * Consumption of protein powders/supplements * Extreme dietary habits (e.g., Atkins diet, very high-protein diets, etc.) * Weight gain or loss of \> 5% in the previous three months. * Excessive alcohol intake (more than 2 drinks per day or 9 per week) * Restrained eating, identified by a score of โ‰ฅ11 on the Eating Habits Questionnaire Inclusion Criteria (short-term study): * Age 14-18 years old (adolescents) or 60-75 years old (older adults) * BMI z-score \>+1SD, \<+2SD (adolescents) or BMI 25-30 kg/m2 (older adults) * Willing to maintain habitual diet, physical activity pattern, and body weight throughout the study. * Willing to maintain current dietary supplement use throughout the study. On study visit days, subject agrees not to take any supplements until dismissal from the Nutrition Intervention Center. * Willing to abstain from alcohol consumption for 24hrs prior to all study visits. * Willing to avoid vigorous physical activity for 24hrs prior to all study visits. * Willing to refrain from cannabis use throughout the entire duration of the study. * Willing to refrain from protein supplement use (e.g. protein powder) throughout the entire duration of the study. * Understands the study procedures, provides informed consent to participate in the study, and authorizes release of relevant protected health information to the study investigator. Exclusion Criteria (short-term study): * Smoking * Thyroid problems * Lactose intolerance and/or allergies, intolerances, or sensitivities to study treatments * Previous history of cardiovascular disease, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, malabsorptive syndrome, pancreatitis, gallbladder or biliary disease * Presence of gastrointestinal disorder or surgeries within the past year. * Inability to comply with the experimental procedures and follow our safety guidelines * Regular breakfast skipping (\>3 days a week) * On a special diet (e.g. ketogenic, Atkins, high protein) or restrained eaters as identified by a score of \>20 on the Eating Attitudes Questionnaire * Difficulties with eating or swallowing * Fasting blood glucose \>5.6mmol/L measured at screening * Uncontrolled hypertension (systolic blood pressure \>120mmHg, diastolic blood pressure \>80mmHg) as defined by the average blood pressure measured at screening * Weight gain or loss of \>10lbs in previous three months * Consuming prescription or non-prescription drug, herbal or nutritional supplements known to affect outcome of the study as per investigator's judgement
๐Ÿ’Š

What it tests

  • Counselling to follow Canada's Food Guide and 3 daily servings of Dairy (long-term study)
  • Dairy (short-term study)
  • Counselling to follow Canada's Food Guide (long-term study)
  • Plant-based alternative (short-term study)
๐Ÿ“

Where

2 sites
Department of Nutritional Sciences
Toronto, Canada
Nutrition Intervention Center
Toronto, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy